Enhancing the activation of T cells through anti‐ CD3 / CD28 magnetic beads by adjusting the antibody ratio
IUBMB Life · 2024-12 · 76 (12) · 1175-1185
DOI: 10.1002/iub.2898 ↗Kurz gefasst
Fachartikel in der Zeitschrift IUBMB Life, online erschienen am 24.07.2024. Verfasst von Yinuo Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, China. Hauptthemen laut MEDLINE: CD28 Antigens, CD3 Complex, Lymphocyte Activation, T-Lymphocytes. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Ministry of Education of the People's Republic of China, Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
The utilization of anti‐CD3/CD28 magnetic beads for T cell expansion in vitro has been investigated for adoptive cell transfer therapy. However, the impact of the CD3/CD28 antibody ratio on T cell differentiation and function remains incompletely elucidated. This study seeks to address this knowledge gap. To begin with, CD3 antibodies with a relatively low avidity for Jurkat cells (Kd = 13.55 nM) and CD28 antibodies with a relatively high avidity (Kd = 5.79 nM) were prepared. Afterwards, anti‐CD3/CD28 antibodies with different mass ratios were attached to magnetic beads to examine the impacts of different antibody ratios on T cell capture, and proliferation. The research demonstrated that the most significant expansion of T cells was stimulated by the anti‐CD3/CD28 magnetic beads with a mass ratio of 2:1 for CD3 antibodies and CD28 antibodies. Moreover, CD25 and PD1 expression of expanded T cells increased and then decreased, with lower CD25 and PD1 expression in the later stages of expansion indicating that T cells were not depleted. These T cells, which are massively expanded in vitro and have excellent expansion potential, can be infused back into the patient to treat tumor patients. This study shows that altering the ratio of anti‐CD3/CD28 antibodies can control the strength of T cell stimulation, thereby leading to the improvement of T cell activation. This discovery can be utilized as a guide for the creation of other T cell stimulation approaches, which is beneficial for the further development of tumor immunotherapy technology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, China.
- Beijing Scipromed Biotech Co., Ltd., Beijing, China.
ORCID-Profile: Yinuo Chen
Förderung
- Ministry of Education of the People's Republic of China
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Chen, Y., Zhao, R., Fan, Q., Liu, M., Huang, Y., & Shi, G. (2024). Enhancing the activation of T cells through anti‐ CD3 / CD28 magnetic beads by adjusting the antibody ratio. IUBMB Life, 76(12), 1175-1185. https://doi.org/10.1002/iub.2898
Vancouver
Chen Y, Zhao R, Fan Q, Liu M, Huang Y, Shi G. Enhancing the activation of T cells through anti‐ CD3 / CD28 magnetic beads by adjusting the antibody ratio. IUBMB Life. 2024;76(12):1175-1185. doi:10.1002/iub.2898
BibTeX
@article{Chen2024,
author = {Chen, Yinuo and Zhao, Rui and Fan, Qi and Liu, Mengmeng and Huang, Yonglin and Shi, Guoqing},
title = {Enhancing the activation of T cells through anti‐ CD3 / CD28 magnetic beads by adjusting the antibody ratio},
journal = {IUBMB Life},
year = {2024},
volume = {76},
number = {12},
pages = {1175--1185},
doi = {10.1002/iub.2898}
}
EUVIMED